Iclusig (ARIAD Pharmaceuticals, Inc.)
Welcome to the PulseAid listing for the Iclusig drug offered from ARIAD Pharmaceuticals, Inc.. This Kinase Inhibitor [EPC],Protein Kinase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | ARIAD Pharmaceuticals, Inc. |
| NON-PROPRIETARY NAME: | ponatinib hydrochloride |
| SUBSTANCE NAME: | PONATINIB HYDROCHLORIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Kinase Inhibitor [EPC],Protein Kinase Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, FILM COATED |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2015-04-22 |
| END MARKETING DATE: | 0000-00-00 |
Iclusig HUMAN PRESCRIPTION DRUG Details:
| Item Description | Iclusig from ARIAD Pharmaceuticals, Inc. |
| LABELER NAME: | ARIAD Pharmaceuticals, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 30(mg/1) |
| START MARKETING DATE: | 2015-04-22 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 76189-533_4d5f7837-cb1f-4f2c-8788-0f9b594fb748 |
| PRODUCT NDC: | 76189-533 |
| APPLICATION NUMBER: | NDA203469 |
Other PONATINIB HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:
